Business Context and Reporting Period
Company: The Hain Celestial Group, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: June 30, 2003
Business Overview: The Company manufactures, markets, and distributes natural, organic, specialty, and snack food products. Key brands include Celestial Seasonings, Terra Chips, Imagine, and Yves Veggie Cuisine. The Company operates in one business segment and relies on a mix of owned manufacturing facilities (42% of revenue in 2003) and independent co-packers (58% of revenue in 2003).
Key Financial Metrics
| Metric (in thousands) | Fiscal 2003 | Fiscal 2002 | Fiscal 2001 |
|---|---|---|---|
| Net Sales | $466,459 | $395,954 | $345,661 |
| Gross Profit | $143,003 | $104,039 | $111,018 |
| Gross Margin | 30.7% | 26.3% | 32.1% |
| Operating Income | $46,159 | $7,264 | $38,379 |
| Net Income | $27,492 | $2,971 | $23,589 |
| Diluted EPS | $0.79 | $0.09 | $0.68 |
| Working Capital | $83,324 | $70,942 | $92,312 |
| Total Assets | $581,548 | $481,183 | $461,693 |
| Long-Term Debt | $59,455 | $10,293 | $10,718 |
| Cash and Cash Equivalents | $10,984 | $7,538 | $26,643 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 17.8% to $466.5 million, driven primarily by acquisitions (Acirca, Grains Noirs, and Imagine Foods) and a full year of operations for businesses acquired in 2002. Normal winter weather also boosted sales of tea and soups compared to the unusually warm winter of 2002.
- Profitability Surge: Net income jumped to $27.5 million from $3.0 million in 2002. This improvement is largely due to the absence of $21.3 million in restructuring and non-recurring charges recorded in fiscal 2002 (related to the Health Valley facility sale and discontinuance of supplements/Weight Watchers licenses).
- Margin Expansion: Gross margin improved to 30.7% from 26.3% (2002), aided by more efficient trade spending and warehousing costs, partially offset by higher ingredient costs and lower margins on European acquisitions.
- Debt Increase: Long-term debt rose significantly to $59.5 million from $10.3 million as the Company utilized its $240 million Credit Facility to fund three major acquisitions in fiscal 2003.
Guidance, Outlook, and Risks
- Acquisition Strategy: Management continues to pursue growth through the acquisition of complementary natural and organic food brands and internal expansion.
- Seasonality: Results are subject to seasonal fluctuations; tea and soup sales are stronger in cooler months, while snack sales peak in warmer months.
- Key Risks:
- Co-packer Dependency: 58% of revenue relies on independent co-packers; loss of a key co-packer could materially disrupt production.
- Regulatory Compliance: Subject to extensive regulation by the FDA, USDA, and FTC regarding organic labeling, genetically modified foods, and trans fatty acid declarations.
- Foreign Exchange: International sales represented 17.3% of total net sales; currency fluctuations impact financial results.
- Competition: Faces competition from large mainstream food companies (e.g., General Mills, Nestle) with greater resources.
- Liquidity: The Company maintains a $240 million revolving credit facility. Management believes cash on hand ($11.0 million) and projected cash flows are sufficient to fund operations and capital expenditures for the next fiscal year.
Investor Verification Checklist
- Acquisition Integration: Verify the successful integration and performance of the three fiscal 2003 acquisitions (Acirca, Grains Noirs, Imagine) against pro forma expectations.
- Co-packer Relationships: Confirm the stability of contracts with key co-packers, particularly for non-dairy beverages and tortilla chips, given the high reliance on third-party manufacturing.
- Restructuring Accruals: Monitor the remaining accrued restructuring charges ($0.6 million) and ensure no additional unexpected costs arise from the Health Valley facility transition.
- Debt Covenants: Review compliance with the Credit Facility covenants, especially given the increased leverage used to fund recent growth.
- Regulatory Changes: Assess the financial impact of upcoming FDA regulations regarding trans fatty acid labeling (effective Jan 1, 2006) and USDA organic certification requirements.